- Видео 104
- Просмотров 6 134
IMPACT Medicom
Канада
Добавлен 7 май 2019
We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic areas. For a description of our work, see: www.impactmedicom.com.
Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape
In this podcast episode, Dr. Versha Banerji discusses the role of non-covalent BTK inhibitors for the treatment of CLL.
Our Guest:
Dr. Versha Banerji is a Clinician Scientist at CancerCare Manitoba and Senior Scientist at the Research Institute in Oncology and Hematology, based in Winnipeg, Manitoba.
If you enjoyed our podcast episode, please review and subscribe. For other medical education content, visit our website at: www.impactmedicom.com
This episode was funded by Eli Lilly, Canada.
Our Guest:
Dr. Versha Banerji is a Clinician Scientist at CancerCare Manitoba and Senior Scientist at the Research Institute in Oncology and Hematology, based in Winnipeg, Manitoba.
If you enjoyed our podcast episode, please review and subscribe. For other medical education content, visit our website at: www.impactmedicom.com
This episode was funded by Eli Lilly, Canada.
Просмотров: 16
Видео
Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape
Просмотров 327 часов назад
In this video capsule, Dr. Versha Banerji discusses the role of non-covalent BTK inhibitors for the treatment of CLL. Our Guest: Dr. Versha Banerji is a Clinician Scientist at CancerCare Manitoba and Senior Scientist at the Research Institute in Oncology and Hematology, based in Winnipeg, Manitoba. If you enjoyed our podcast episode, please review and subscribe. For other medical education cont...
Highlights from EHA 2024 - Updates on the Treatment of CLL
Просмотров 662 месяца назад
In this podcast episode, three of Canada’s top hematologists discuss data on the treatment of CLL presented at the European Hematology Association (or EHA) meeting in Madrid, Spain. The discussion involves an analysis of the data from 6 oral presentations on combination and novel therapies for the treatment of CLL. In this discussion, the data is put into the Canadian context, with key take-awa...
EHA 2024 - Updates on CLL with Dr. Banerji, Dr. Assouline, and Dr. Hillis
Просмотров 2352 месяца назад
In this video capsule, 3 of Canada’s top hematologists discuss data on the treatment of CLL presented at the European Hematology Association (or EHA) meeting in Madrid, Spain. The discussion involves an analysis of the data from 6 oral presentations on combination and novel therapies for the treatment of CLL. In this discussion, the data is put into the Canadian context, with key take-aways tha...
LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL
Просмотров 432 месяца назад
In this episode of our podcast, recorded at the European Hematology Association (EHA) meeting in Madrid, Spain, we discuss updated results of the BGB-11417-101 trial with Dr. Stephen Opat. The BGB-11417-101 trial examined the efficacy and safety of sonrotoclax plus zanubrutinib for the treatment of R/R CLL. Our Guest: Dr. Stephen Opat is the director of Clinical Haematology at Monash Health, fo...
Cutting Edge Advances in the Treatment of Lung Cancer
Просмотров 73 месяца назад
In this episode, Dr. Barbara Melosky discusses cutting edge approaches to the treatment of Lung Cancer, including the use of artificial intelligence and novel therapeutic approaches such as cancer vaccines and new targeted therapies. Our Guest: Dr. Barbara Melosky Dr Melosky is a Professor of Medicine at the University of British Columbia and a Medical Oncologist in Vancouver at BC Cancer. Dr. ...
Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers
Просмотров 33 месяца назад
Welcome to our podcast episode on diagnostic, prognostic and predictive biomarkers for the treatment of upper GI cancers. In this episode, Dr Brezden-Masley (medical oncologist) and Dr Streutker (pathologist) discuss the latest biomarkers that may inform treatment of upper GI cancer. Our Guests: Dr. Christine Brezden-Masley Dr. Brezden-Masley is a Medical Oncologist and the Director of the Marv...
Immunotherapy for Kidney Transplant Patients with Skin Cancer
Просмотров 73 месяца назад
In this podcast episode, Dr. Evan Lipson discusses the use of immunotherapy for patients with skin cancer who have had a kidney transplant. Our guest: Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and ...
Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective
Просмотров 553 месяца назад
In this video capsule, Dr. Mark Taylor discusses the surgical implications for the treatment of cSCC. This podcast episode is best viewed alongside the slides, which can be found in the video capsule version: ruclips.net/video/uk5JEUjbkDE/видео.html. Our Guest: Dr. S. Mark Taylor is a Facial Plastic and Reconstructive surgeon in Halifax, Nova Scotia. He is currently a Professor of Surgery at Da...
Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective
Просмотров 757 месяцев назад
In this video capsule, Dr. Mark Taylor discusses the surgical implications for the treatment of cSCC. Our Guest: Dr. S. Mark Taylor is a Facial Plastic and Reconstructive surgeon in Halifax, Nova Scotia. He is currently a Professor of Surgery at Dalhousie University. His expertise and clinical interest includes rhinoplasty/nasal surgery, eyelid surgery, management of facial paralysis, facial sk...
Immunotherapy for Kidney Transplant Patients with Skin Cancer
Просмотров 1077 месяцев назад
In this video capsule, Dr. Evan Lipson discusses the use of immunotherapy for patients with skin cancer who have had a kidney transplant. Our guest: Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Ca...
Highlights from ASH 2023: A Canadian Perspective on CLL
Просмотров 4398 месяцев назад
In this video capsule, Dr. Versha Banerji and Dr. David MacDonald discuss the key CLL presentations at ASH 2023 and their impact on clinical practice in Canada. Our Guests Dr. David Macdonald: Dr. David Macdonald is a hematologist at The Ottawa Hospital. He has a busy clinical practice, is actively involved in clinical trials in lymphoma, and is Director of the CORE malignant hematology clinica...
LIVE FROM ASH 2023: Isa-CYBORD induction chemotherapy in newly diagnosed, transplant eligible MM
Просмотров 63 месяца назад
In this podcast episode, Dr. Rami Kotb and Dr. Donna Reece discuss results of the CMRG Isa-CYBORD trial presented at the ASH 2023 meeting, and the implications of the results for Canadian clinical practice. Our Guests: Dr. Rami Kotb is a physician in the Division of Hematology, Department of Medical Oncology & Hematology at CancerCare Manitoba, Winnipeg, MB, Canada Dr Donna Reece is the Directo...
LIVE FROM ASH 2023: Isa-CYBORD induction chemotherapy in newly diagnosed, transplant eligible MM
Просмотров 868 месяцев назад
In this video capsule, Dr. Rami Kotb and Dr. Donna Reece discuss results of the CMRG Isa-CYBORD trial presented at the ASH 2023 meeting, and the implications of the results for Canadian clinical practice. Our Guests: Dr. Rami Kotb is a physician in the Division of Hematology, Department of Medical Oncology & Hematology at CancerCare Manitoba, Winnipeg, MB, Canada Dr Donna Reece is the Director ...
Live from ASH 2023: Dr Brown Discusses Updated Results of the ALPINE Trial in CLL
Просмотров 193 месяца назад
In this episode of our podcast, recorded at the American Society of Hematology (ASH) in San Diego, California, we discuss updated results of the ALPINE trial with Dr. Jennifer Brown. The ALPINE trial examined the efficacy and safety of zanubrutinib versus ibrutinib for the treatment of CLL. Our Guest: Dr. Jennifer Brown is the Director of the CLL Center of the Division of Hematologic Malignanci...
First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: 1L LA/mUC
Просмотров 9910 месяцев назад
First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: 1L LA/mUC
First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on ...
Просмотров 73 месяца назад
First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on ...
First-line treatment strategies for the management of la/mUC: S2 Ep 4 - Round Table Discussion
Просмотров 5710 месяцев назад
First-line treatment strategies for the management of la/mUC: S2 Ep 4 - Round Table Discussion
First-line treatment strategies for the management of la/mUC: S2 Ep 3 - Case Discussion
Просмотров 7110 месяцев назад
First-line treatment strategies for the management of la/mUC: S2 Ep 3 - Case Discussion
First-line treatment strategies for the management of la/mUC: S2E2 1L Treatment by Dr Friedlander
Просмотров 20911 месяцев назад
First-line treatment strategies for the management of la/mUC: S2E2 1L Treatment by Dr Friedlander
First-line treatment strategies for the management of la/mUC: S2E1 Unmet Needs by Dr Blais
Просмотров 15811 месяцев назад
First-line treatment strategies for the management of la/mUC: S2E1 Unmet Needs by Dr Blais
First Line la/mUC Evolving Treatment Strategies: S2 Ep 2 - First-Line Treatment
Просмотров 33 месяца назад
First Line la/mUC Evolving Treatment Strategies: S2 Ep 2 - First-Line Treatment
First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion
Просмотров 33 месяца назад
First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion
First Line la/mUC Evolving Treatment Strategies: S2 Ep 1 - Unmet Needs
Просмотров 23 месяца назад
First Line la/mUC Evolving Treatment Strategies: S2 Ep 1 - Unmet Needs
First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion
Просмотров 53 месяца назад
First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion
Prise en charge des cancers indolents touchant les lymphocytes B, traités par des BTKis
Просмотров 128Год назад
Prise en charge des cancers indolents touchant les lymphocytes B, traités par des BTKis
Management of BTKi Associated Adverse Events: A Pharmacist's Perspective
Просмотров 155Год назад
Management of BTKi Associated Adverse Events: A Pharmacist's Perspective
Monoclonal Antibodies as COVID-19 Prophylaxis in Immunocompromised Patients
Просмотров 117Год назад
Monoclonal Antibodies as COVID-19 Prophylaxis in Immunocompromised Patients
Video Series - Urothelial Carcinoma: Management of EV AEs - Chapter 4: Hyperglycemia
Просмотров 57Год назад
Video Series - Urothelial Carcinoma: Management of EV AEs - Chapter 4: Hyperglycemia
Precision Medicine Series: Ep14: External Quality Assurance in Biomarker Testing
Просмотров 63 месяца назад
Precision Medicine Series: Ep14: External Quality Assurance in Biomarker Testing
Has there been a trial on venetoclax and a BTK inhibitor on patients on watch and wait with low risk markers?
What is a health care profesional? Do you mean a janitor or MD? I am just a PhD and k ow you are liars.